2026-2034年全球辅助生殖技术市场规模、份额、趋势和成长分析报告

辅助生殖技术（ART）市场预计将从 2025 年的 515.8 亿美元成长到 2034 年的 1,245.5 亿美元，2026 年至 2034 年的复合年增长率为 10.29%。

近年来，受不孕症发病率上升和人们对先进不孕症治疗方法认知度提高的推动，全球辅助生殖技术（ART）市场经历了显着增长。晚育、生活方式改变以及影响生育能力的疾病等因素，都促使人们对包括体外受精（IVF）和卵胞浆内单一精子注射（ICSI）在内的辅助生殖技术的需求不断增长。不孕症治疗接受度的提高和成功率的提升，也鼓励了更多夫妇选择辅助生殖技术。

生殖医学领域的技术进步在辅助生殖技术（ART）市场的扩张中发挥了至关重要的作用。诸如延时胚胎成像、基因筛检和冷冻保存等创新技术提高了治疗效果，增强了患者的信心。此外，已开发国家和发展中国家生育诊所和专业生殖医学中心的扩张，提高了获得ART服务的机会，并进一步推动了市场成长。

展望未来，由于多个国家加大对不孕症研究的投入以及政府的支持措施，预计市场将强劲成长。此外，单亲家庭和同性伴侣抚养子女的社会接受度不断提高，预计也将推动对辅助生殖技术（ART）服务的需求成长。同时，生殖技术的进步和治疗成本的降低，预计在未来几年为市场相关人员创造巨大的商机。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球辅助生殖科技市场：依方法划分

• 市场分析、洞察与预测
• 体外受精（IVF）
• 人工授精（AI-IUI）
• 冷冻胚胎移植（FET）
• 其他的

第五章：全球辅助生殖技术市场：依手术类型划分

• 市场分析、洞察与预测
• 新鲜捐赠者
• 非新鲜捐赠者
• 冷冻捐赠者
• 非冷冻捐赠者

第六章：全球辅助生殖科技市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 不孕症治疗诊所

第七章 全球辅助生殖科技市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bloom IVF Centre
  • California Cryobank
  • CARE Fertility
  • Monash IVF Group
  • Carolinas Fertility Institute
  • European Sperm Bank
  • INVO Bioscience
  • Apollo Hospitals Enterprise Ltd
  • The Cooper Companies
  • Vitrolife AB

The Assisted Reproductive Technology Market size is expected to reach USD 124.55 Billion in 2034 from USD 51.58 Billion (2025) growing at a CAGR of 10.29% during 2026-2034.

The global Assisted Reproductive Technology (ART) market has experienced significant growth in recent years due to the rising prevalence of infertility and increasing awareness about advanced fertility treatments. Factors such as delayed parenthood, lifestyle changes, and medical conditions affecting fertility have contributed to higher demand for ART procedures including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Growing acceptance of fertility treatments and improved success rates have also encouraged more couples to consider assisted reproductive options.

Technological advancements in reproductive medicine have played a crucial role in expanding the ART market. Innovations such as time-lapse embryo imaging, genetic screening technologies, and cryopreservation techniques have improved treatment outcomes and increased patient confidence. Additionally, the expansion of fertility clinics and specialized reproductive centers across developed and developing regions is enhancing accessibility to ART procedures, further driving market growth.

Looking ahead, the market is expected to witness strong expansion due to increasing investments in fertility research and supportive government initiatives in several countries. Growing social acceptance of single parenthood and same-sex parenting is also expected to boost demand for ART services. Furthermore, advancements in reproductive technologies and improved affordability of treatments are likely to create significant opportunities for market players in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technique

• In Vitro Fertilization (IVF)
• Artificial Insemination (AI-IUI)
• Frozen Embryo Transfer (FET)
• Others

By Procedure

• Fresh Donor
• Fresh Non-donor
• Frozen Donor
• Frozen Non-donor

By End User

• Hospitals
• Fertility Clinics

COMPANIES PROFILED

• Bloom IVF Centre, California Cryobank, CARE Fertility, Monash IVF Group, Carolinas Fertility Institute, European Sperm Bank, INVO Bioscience, Apollo Hospitals Enterprise Ltd, The Cooper Companies, Vitrolife AB
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technique
• 4.2. In Vitro Fertilization (IVF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Artificial Insemination (AI-IUI) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Frozen Embryo Transfer (FET) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Fresh Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Fresh Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Frozen Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Frozen Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Fertility Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technique
  • 7.2.2 By Procedure
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technique
  • 7.3.2 By Procedure
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technique
  • 7.4.2 By Procedure
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technique
  • 7.5.2 By Procedure
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technique
  • 7.6.2 By Procedure
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bloom IVF Centre
  • 9.2.2 California Cryobank
  • 9.2.3 CARE Fertility
  • 9.2.4 Monash IVF Group
  • 9.2.5 Carolinas Fertility Institute
  • 9.2.6 European Sperm Bank
  • 9.2.7 INVO Bioscience
  • 9.2.8 Apollo Hospitals Enterprise Ltd
  • 9.2.9 The Cooper Companies
  • 9.2.10 Vitrolife AB